Anticancer Therapies – News and Features

Company has initiated the United States trial evaluating the safety and efficacy of -101 in patients with platinum-sensitive ovarian cancer.

Epistem, the UK biotechnology company and Rottapharm Madaus, the multinational pharmaceutical company today announced that favourable results have been obtained with the prophylactic use of CR 3294 in a series of preclinical models for intestinal mucositis.

Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin

Almac Diagnostics has announced details of a global multi-centre collaborative lung cancer study with leading research organisations in the USA, Canada, Asia and Europe.

The researchers have patented an efficient technique that allows algae extract to be further evaluated for tailored cell-killing traits.

Geron Corporation has announced the enrollment of the first patient in a clinical trial of its telomerase inhibitor drug, GRN163L, in locally recurrent or metastatic breast cancer.

The first clinical trial to use an HIV drug as cancer therapy has shown that it can help increase chances of recovery from pancreatic cancer.

Cancer biologists are turning their attention to learn how tumor growth might be stopped at the earliest opportunity.

Medulloblastomas are driven by mutation-altered stem/progenitor cells of the normal brain study shows.

The researchers traced ascorbate's anti-cancer effect to the formation of hydrogen peroxide in the extracellular fluid surrounding the tumors.